Why Medicine Is Failing Women — By Design

Updated: May 26, 2026

Why Medicine Is Failing Women — And Why That's Not an Accident

If you've read the posts in this series, you've watched the pattern build.

A policy decision in Wisconsin that replaced physician depth with cheaper credentials. A lawsuit against a directory that helped Black patients find doctors who understood their bodies. A healthcare system designed to deny, delay, and defer while collecting premiums that patients pay into faithfully, without any guarantee the money will be there when they actually need it.

Each one of those decisions was framed as something else. Access. Equality. Efficiency. Cost management.

But if you follow the outcomes — who gets believed, who gets treated, who gets better, and who doesn't — the framing doesn't hold.

Equal Process Is Not the Same as Equal Outcomes

Do No Harm — the organization that sued Find A Black Doctor and has made dismantling DEI in medicine its stated mission — argues that medicine should be race-neutral. That treating patients as individuals rather than demographic groups is the path to equality.

I want to sit with that argument for a moment. Because it sounds reasonable until you look at what it produces.

Black women in America still die in childbirth at rates that have no business existing in a developed nation with the healthcare spending of the United States. The maternal mortality data isn't new. It isn't improving at a meaningful rate. It isn't explained by income alone, or access alone, or any single variable that a race-neutral policy could address. Research has found that Black women with college degrees and financial stability die in childbirth at higher rates than white women without those advantages. That's not a socioeconomic story. That's a story about what happens inside the room when a Black woman describes pain.

Black women carry longer, more severe menopause symptoms than any other group in the SWAN study — the most comprehensive longitudinal study of the menopause transition ever conducted. More sleep disruption. More cardiovascular risk. More depression. More years of symptoms before anyone offers meaningful treatment.

If outcomes are still unequal after decades of the same process, the process was never equal. Calling for race-neutral care in a system that produces race-specific harm isn't neutrality. It's preservation of the conditions that produce the harm.

The Model Was Built Around a Different Body

Here's the part that doesn't make it into the policy debates often enough.

The research foundation of modern medicine was built primarily on male subjects. The Physicians' Health Study, the Multiple Risk Factor Intervention Trial, the Framingham Heart Study — foundational cardiovascular research that shaped clinical guidelines for decades — enrolled predominantly or exclusively men. Women were excluded from clinical trials for most of the twentieth century, ostensibly to protect them from experimental risk. What that exclusion actually produced was a century of clinical guidelines calibrated to a body that wasn't theirs.

Women present heart attacks differently. Women metabolize drugs differently. Women experience pain differently. Women's immune systems respond differently. None of this was adequately studied for most of the history of evidence-based medicine. The evidence base wasn't built for them.

So when a woman sits in a clinical office and her symptoms don't match the template, she isn't a diagnostic puzzle. She's a body that was never adequately included in the research that built the template. The gap between her experience and the clinical model isn't a failure of her body. It's a failure of the model.

For neurodivergent women — autistic, ADHD, and the many who have never received a diagnosis but have spent decades functioning in a world not designed for their nervous system — the gap is wider. Their presentation doesn't match the template either. Their symptoms land differently, are described differently, and are interpreted differently by a clinical system that was built around neurotypical presentation as the default.

This is why so many women hear the same thing on repeat. You're stressed. Your labs are normal. It might be anxiety. Come back in three months.

The labs being normal and the life being abnormal are not contradictory. They're a sign that the wrong things are being measured.

What Equal Outcomes Would Actually Require

If we're serious about equal outcomes — and not just equal process — we have to be willing to name what produced the unequal outcomes in the first place.

A research base that excluded women. Clinical guidelines calibrated to a different body. A healthcare delivery system designed around throughput rather than pattern recognition. A workforce pipeline being systematically narrowed at exactly the points where cultural competence and lived understanding are most concentrated. A prior authorization apparatus that functions as a profit mechanism dressed as a quality control measure. A training culture that taught physicians to comply, perform, and not make too much noise — and then produced physicians too burned out and too constrained to give patients the time their complexity requires.

None of that is fixed by removing race from a directory. None of that is fixed by replacing physicians with cheaper credentials. None of that is fixed by telling women to reduce stress and come back in three months.

Equal outcomes require building the model differently. From the beginning. Around the bodies that were left out of the original design.

This Is Why the Nervous System Eats First

That phrase isn't a slogan. It's a conclusion I've made based on the cultural zeitgeist and the stories presented in this series has named.

Before a woman can sleep, focus, recover, metabolize, or feel steady in her body, her nervous system has to stop interpreting her environment as a threat. Our healthcare system has dismissed her symptoms, denied her claims, shortened her visits, and removed the physicians most likely to understand her, which isn't neutral background noise. It's an active input into her nervous system. It's part of the stress load her body is trying to manage. It's part of why the standard protocol doesn't work the way the textbook says it should.

You can't out-supplement a dysregulated nervous system. You can't out-hormone a body that's still absorbing the cost of a system that keeps telling it the problem isn't real.

That's what medicine is getting wrong. And it isn't getting it wrong by accident.

What Comes Next

This post is the end of Act One.

Hopefully I've made the case here. The fracture in our healthcare system started in policy. It's moved through our workforce like a cancer. It's landed in the bodies of our patients. The women carrying the heaviest burden were the first to name it, and the system that produced the burden has spent a considerable amount of energy making sure that naming stays contained to a paragraph, a slide, or a diversity section before the speaker returns to the same model.

In act Two I will propose an alternative solution for women I care for. Not as wellness theater, or a protocol borrowed from a research base that wasn't built for you, but a framework built around the nervous system, the stress load, the gut, and the sleep — in the body you actually live in.

That's where the Color Archetype Quiz begins. Not as a diagnosis. As the first accurate map.

Take the Next Step

If this series has named something you've been living but haven't had language for, start here. The Color Archetype Quiz takes five minutes and gives you a starting point that was built for your nervous system — not the one the standard model assumed you had.

Take the Free Color Archetype Quiz → quiz.drstaceydenise.com/color-archetype-start-here

Sources

• SWAN — Study of Women's Health Across the Nation. swanstudy.org

• Perez, Caroline Criado. Invisible Women: Data Bias in a World Designed for Men. 2019.

• CDC. Maternal Mortality Rates in the United States. cdc.gov/nchs/maternal-mortality

Dr. Stacey Denise is a board-certified surgeon transitioned into lifestyle medicine specializing in the menopause transition. She sees patients in California, Georgia, Kentucky, Maryland, Ohio, Texas, and Virginia.